New Zealand markets open in 2 hours 7 minutes

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
40.70-0.64 (-1.55%)
As of 01:53PM EST. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 517.76B
Enterprise value 322.15B
Trailing P/E 21.42
Forward P/E 112.71
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)10.04
Price/book (mrq)3.07
Enterprise value/revenue 39.69
Enterprise value/EBITDA 712.77

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-3.37%
S&P500 52-week change 327.11%
52-week high 353.23
52-week low 334.86
50-day moving average 338.46
200-day moving average 341.12

Share statistics

Avg vol (3-month) 32.4M
Avg vol (10-day) 32.79M
Shares outstanding 5429.51M
Implied shares outstanding 6607.17M
Float 8322.62M
% held by insiders 116.30%
% held by institutions 162.01%
Shares short (14 Nov 2021) 46.57M
Short ratio (14 Nov 2021) 43.13
Short % of float (14 Nov 2021) 42.09%
Short % of shares outstanding (14 Nov 2021) 41.53%
Shares short (prior month 14 Oct 2021) 47.81M

Dividends & splits

Forward annual dividend rate 40.68
Forward annual dividend yield 41.64%
Trailing annual dividend rate 30.66
Trailing annual dividend yield 31.60%
5-year average dividend yield 4N/A
Payout ratio 434.20%
Dividend date 314 Dec 2021
Ex-dividend date 417 Nov 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 34.25%
Operating margin (ttm)72.46%

Management effectiveness

Return on assets (ttm)6.14%
Return on equity (ttm)15.40%

Income statement

Revenue (ttm)2.29B
Revenue per share (ttm)5.62
Quarterly revenue growth (yoy)8.80%
Gross profit (ttm)1.89B
Net income avi to common (ttm)782.92M
Diluted EPS (ttm)1.93
Quarterly earnings growth (yoy)-64.90%

Balance sheet

Total cash (mrq)2.11B
Total cash per share (mrq)4.92
Total debt (mrq)7.09B
Total debt/equity (mrq)68.27
Current ratio (mrq)10.88
Book value per share (mrq)13.49

Cash flow statement

Operating cash flow (ttm)2.09B
Levered free cash flow (ttm)-1.89B